Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Mhatre Rohin, Director. Director active across 2 companies, notably Repligen CORP. Cumulatively, 5 reports have been recorded. Activity tracked since 13 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Rohin Mhatre is a Board Member at Repligen Corp. In this role, he contributes to corporate governance and strategic decision-making. His experience in the biopharmaceutical sector allows him to provide valuable expertise to the board.